Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Artificial Intelligence In Epidemiology Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The artificial intelligence in epidemiology market has seen substantial expansion in recent years. Its valuation is anticipated to climb from $0.83 billion in 2025 to $1.09 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 30.0%. This historical growth can be attributed to several factors including the growth of infectious disease outbreaks, increasing availability of health data, adoption of digital public health tools, government focus on disease surveillance, and the need for faster outbreak response.
The artificial intelligence in epidemiology market is set for considerable expansion over the coming years, with its size projected to reach $3.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 30.7%. This growth during the forecast period is primarily driven by increased investment in AI for public health, the broadening adoption of cloud-based epidemiology platforms, a strong demand for early warning systems, the integration of health data from multiple sources, and a sharpened focus on pandemic preparedness. Noteworthy trends for the forecast period include AI-driven predictions of disease outbreaks, real-time epidemiological surveillance systems, sophisticated population health analytics, the use of predictive modeling for public health planning, and the development of integrated data platforms specifically for epidemiology.
Download A Free Sample Report For Comprehensive Market Insights:
#Artificial Intelligence In Epidemiology Market Growth Factors: Which Forces Are Supporting Market Expansion?
The increasing prevalence of chronic illnesses is anticipated to drive the expansion of artificial intelligence within the epidemiology market in the coming years. Chronic conditions are defined as health issues or diseases with lasting or persistent effects, typically enduring for at least three months, and potentially worsening over time. AI holds a crucial function in multiple areas of chronic disease epidemiology, such as predicting risks, modeling disease progression, and facilitating early detection and diagnosis. For example, as reported in May 2023 by The United Nations (UN), a US-based intergovernmental organization focused on fostering international cooperation and upholding global peace and security, chronic diseases account for seven out of 10 deaths in the US, resulting in over 1.7 million American fatalities annually. Consequently, the rising impact of chronic diseases is poised to fuel the advancement of artificial intelligence in the epidemiology market.
Artificial Intelligence In Epidemiology Market Segmentation: How Is The Market Structured Across Key Categories?
The artificial intelligence in epidemiology market covered in this report is segmented –
1) By Component: Software, Services
2) By Deployment: Web-Based, Cloud-Based
3) By Application: Infection Prediction And Forecasting, Disease And Syndromic Surveillance
4) By End-Use: Government And State Agencies, Research Laboratories, Pharmaceutical And Biotechnology Companies, Healthcare Providers
Subsegments:
1) By Software: Data Analytics Platforms, Predictive Modeling Tools, Geographic Information Systems (GIS), Surveillance Systems, Reporting And Visualization Tools
2) By Services: Consulting Services, Implementation And Integration Services, Data Management And Support Services, Training And Capacity Building Services
Artificial Intelligence In Epidemiology Market Strategic Trends: What Is Defining The Next Phase Of Growth?
Leading companies in the artificial intelligence in epidemiology market are focusing on developing innovative technologies, such as AI-powered imaging platforms for managing diseases, to secure their market presence. For example, in April 2023, Twinn Health, a US-based firm specializing in fitness, AI, and machine learning, launched an AI-driven imaging platform for the prompt detection of age-related diseases. This new platform is notable as the first to incorporate magnetic resonance imaging (MRI) data for assessing frailty risk. It functions as a powerful instrument for early intervention and prevention, as it identifies chronic age-related conditions earlier than conventional molecular signals and aids in their management during initial stages.
Artificial Intelligence In Epidemiology Market Competitive Landscape And Leading Companies
Major companies operating in the artificial intelligence in epidemiology market are Alphabet Inc.; Microsoft Corporation; Roche Holding AG; Pfizer Inc.; Johnson & Johnson Services Inc.; Amazon Web Services Inc.; Google LLC; Intel Corporation; IBM Corporation; Merck & Co. Inc.; Novartis International AG; Sanofi S.A; Bristol Myers Squibb Company; AstraZeneca PLC; Oracle Corporation; GlaxoSmithKline plc; NVIDIA Corporation; Bayer Healthcare; Siemens Healthineers AG; Koninklijke Philips N.V.; SAS Institute Inc.; Epic Systems Corporation; Cerner Corporation; eClinicalWorks LLC; Meditech; Komodo Health; Metabiota Inc.
Access The Complete Artificial Intelligence In Epidemiology Market Report:
Artificial Intelligence In Epidemiology Market Leading Geography: Which Region Generates The Most Revenue?
North America was the largest region in the artificial intelligence in epidemiology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in epidemiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.